NCT00913913 2015-12-01
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
Dartmouth-Hitchcock Medical Center
Phase 2 Terminated
Clinical Trials
1 trialsTerminated × Carcinoma, Renal Cell × lentiviral minigene vaccine of COVID-19 coronavirus × Clear all